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Expression of the innate immune 
receptor LILRB5 on monocytes 
is associated with mycobacteria 
exposure
Louise E. Hogan1,2, Des C. Jones3 & Rachel L. Allen1
Antigen presenting cells (APC) are critical components of innate immunity and consequently shape the 
adaptive response. Leukocyte Ig Like Receptors (LILR) are innate immune receptors predominantly 
expressed on myeloid cells. LILR can influence the antigen presenting phenotype of monocytic cells 
to determine the nature of T cell responses in infections including Mycobaterium leprae. We therefore 
investigated the relevance of LILR in the context of Mycobacterium tuberculosis. Real-time PCR studies 
indicated that the transcriptional profile of the orphan receptor LILRB5 was significantly up-regulated 
following exposure to mycobacteria. Furthermore, LILRA1 and LILRB5 were able to trigger signalling 
through direct engagement of mycobacteria using tranfectant cells incorporating a reporter system. We 
describe for the first time the expression of this receptor on T cells, and highlight the potential relevance 
to mycobacterial recognition. Furthermore, we demonstrate that crosslinking of this receptor on T cells 
increases proliferation of cytotoxic, but not helper, T cells.
Leukocyte immunoglobulin-like receptors (LILR) are a group of receptors with activating or inhibitory functions, 
that are expressed on the surface of myelomonocytic cells, including antigen presenting cell subsets. In addition 
to their classification as activatory (LILRA1-2, 4–6) or inhibitory (LILRB1-5) on the basis of signalling motifs, 
LILR are designated as group I or group II on the basis on their predicted ability to bind MHC class I (MHC-I)1,2. 
Through their expression on monocytic cells LILR have been shown to regulate TLR activity3–9, antigen present-
ing phenotype10–13 and cytokine secretion profile7,14,15, thus demonstrating the potential to influence subsequent 
immune responses4,16–18. Variations in the strength of binding of LILRB2 to different HLA alleles expressed by 
HIV infected patients was recently shown to correlate with control of infection19.
In Mycobacterium leprae (M. Leprae) infection, LILR are thought to be responsible for influencing the immune 
response and their expression profile has been shown to correlate with disease phenotype. Comparison of lepro-
matous and tuberculoid leprosy samples showed increased expression of LILRA2 in the skin lesions of patients 
with lepromatous leprosy, a disease profile associated with disseminated disease and ineffective bacilli clearance 
resulting from a Th2 biased response. This is in contrast to tuberculoid leprosy, in which a strong Th1 biased 
response enables the effective clearance of bacilli from localised infection. Crosslinking of LILRA2 on mac-
rophages resulted in a 40% reduction in intracellular killing of mycobacteria, indicating that LILRA2 may inhibit 
anti-microbial functions in macrophages. The ligation of LILRA2 also considerably reduced the induction of 
IL-12 production by TLRs, skewing cytokine activity towards a Th2 biased response4,20.
As there is evidence for LILR-mediated modulation of immune responses during M. leprae infection, it is 
possible that the expression and functions of these receptors are relevant during infection with other mycobac-
teria such as Mycobacterium tuberculosis (M. tb). In support of this, the up-regulation of HLA-G, the highest 
affinity self-ligand for LILRB1 and LILRB2, has been documented by both gene expression assays21 and surface 
expression analysis of macrophages from patients with M. tb22. LILRB1 expression on NK cells correlates with 
disease severity in pulmonary tuberculosis23, while expression on CD4 T cells, together with CD152 has been 
proposed to regulate cytolytic activity24. Furthermore, TLR2/1/6 heterodimers, TLR4, TLR8, and TLR9 and are 
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implicated in the initial recognition of M.tb, and the regulation of these receptors may contribute to down-stream 
responses25–29. We therefore decided to investigate the potential role of LILR in the context of M. tb infection.
Tuberculosis per se, primarily results from infection with the organism M. tb, but there have been documented 
cases indicating Mycobacterium bovis (M. bovis) as a causative agent30,31. Furthermore, the attenuated strain of 
M. bovis used in vaccinations, Bacillus Calmette-Guérin (BCG), causes disease in immunocompromised indi-
viduals32. We therefore hypothesized that LILR responses may vary between mycobacterial species. Furthermore, 
non-specific protection arising from various live vaccinations is thought to develop through epigenetic changes 
in the innate immune environment33. This led us to consider that prior BCG vaccination may exert a relevant 
effect on monocytic cell phenotype. To elucidate the mechanisms involved, we sought to compare LILR expres-
sion profiles for antigen presenting cells (APC) exposed to M. tb, M. bovis, and BCG comparing cells from BCG 
vaccinated and unvaccinated donors.
LILR can interact directly with bacteria, specifically, LILRB1 and LILRB3 have been shown to bind bacteria 
including E. coli, H. pylori and S. aureus34 with individual receptors varying in their bacterial specificity. The bac-
terial ligand(s) involved in this interaction are yet to be determined in full, although lipoteichoic acid on S. aureus 
has been suggested as one potential ligand35. Therefore, it is also possible that LILR may directly interact with 
one or more mycobacterial ligands. As LILR regulate TLR activity, any potential interaction with mycobacterial 
antigens could have a distinct impact on the resulting immune response.
Here, we describe variations in LILR profile between APC derived from BCG vaccinated and unvacci-
nated individuals, which indicate that BCG vaccination decreases the expression of LILRA3 and LILRB2 on 
monocyte-derived macrophages. Moreover, LILRB5 is up-regulated in monocyte-derived DC in response to 
mycobacterial species, significantly so after BCG exposure. Furthermore, BCG elicits LILRA1 and LILRB5 sig-
nalling in a reporter system. Finally, we describe for the first time LILRB5 expression on T cells, and demonstrate 
that ligation of LILRB5 on T cells induces CD8, but not CD4, T cell proliferation.
Results
Comparison of LILR expression profiles for BCG vaccinated and unvaccinated donors. To date, 
LILR expression profile studies have been hindered by a lack of specific monoclonal antibodies for each mem-
ber of the receptor family. As such, we analysed the 11 human LILR using a Real-Time PCR assay. Distinct 
mRNA profiles of LILR expression were observed for both in vitro monocyte-derived macrophages (MDM) and 
monocyte-derived DC (moDC) from BCG vaccinated vs. unvaccinated donors (Fig. 1). Statistically significant 
differences were seen for two of the eleven LILR in MDM. Most strikingly, LILRA3, the only LILR to lack any 
transmembrane or cytoplasmic domain, had significantly (p = 0.027) lower expression on MDM samples from 
BCG vaccinated donors compared with unvaccinated donors. LILRB2 was also expressed at lower levels by MDM 
from vaccinated donors (p = 0.025). As both of these receptors are known to have inhibitory functions, this may 
be a potentially beneficial finding in the presence of mycobacterial infection.
BCG vaccination affects LILR expression profiles in the presence of mycobacteria. LILR mRNA 
expression profiles were then compared for moDC and MDM following in vitro culture with BCG, M. bovis and 
M. tb (H37Rv). Donors were grouped based on their BCG vaccination status.
In dendritic cell cultures, LILRA3 was down-regulated following culture with all three organisms for moDC 
derived from unvaccinated donors; however, this down-regulation was only significant following M. bovis expo-
sure (p = 0.028) (Fig. 2). These effects were not detected for moDC derived from BCG vaccinated donors. The 
most striking results were seen for LILRB5, in which moDC derived from BCG vaccinated donors up-regulated 
LILRB5 following exposure to all three mycobacteria, significantly so following culture with BCG (p = 0.034). 
These changes in expression were not observed for moDC derived from unvaccinated donors.
For macrophage cultures, LILRA3 was again down-regulated following exposure to M. bovis and H37RV, sig-
nificantly so for M. bovis (p = 0.047) in BCG unvaccinated donors (Fig. 3). Furthermore, following culture with 
BCG and H37Rv, MDM derived from BCG vaccinated donors expressed significantly less LILRA3 compared to 
their unvaccinated counterparts (BCG: p = 0.047, H37Rv: p = 0.047). LILRB2 was also found to be expressed in 
significantly higher levels following H37Rv culture on MDM derived from unvaccinated donors, than their BCG 
vaccinated counterparts (P = 0.028).
It is interesting to note that LILRB5 is the only receptor up-regulated in response to mycobacterial exposure, 
which may indicate a more distinct role for this receptor in M. tb infection. In order to examine the potential 
relevance of this we proceeded to examine direct binding within a reporter system.
BCG elicits LILRA1 and LILRB5 signalling in a reporter system. Binding of whole bacteria by indi-
vidual LILR and PIR has been demonstrated in previous studies34,35 with lipoteichoic acid suggested as a potential 
bacterial ligand for these receptors35. It is therefore possible that a subset of LILR could engage components of M. 
tb, M. bovis or BCG through a similar process. To determine whether any members of the LILR family may be 
capable of direct interaction with mycobacteria, a panel of 2B4 reporter cell lines each expressing an NFAT-GFP 
(Nuclear Factor of Activated T cell–Green Fluorescent Protein) reporter construct and a LILR-CD3ζ construct 
were used. As 2B4 is a T cell hybridoma cell line, it would not be expected to internalise mycobacteria. Signalling 
transfectants of LILRA1, LILRA2, LILRB1, LILRB3, LILRB5 and LILR-negative controls were used to determine 
whether signalling was induced in the presence of M. bovis (heat-killed), M. tb (heat-killed) and BCG (live). No 
equivalent transfectants of LILRA3, LILRA4, LILRA5, LILRA6, LILRB2 or LILRB4 were used (Fig. 4).
The results indicate that BCG can interact with both LILRA1 and LILRB5 to induce signalling through the 
CD3ζ construct in this system. A slight shift in fluorescence was detectable for LILRA1 transfectants incubated 
with M. bovis, which may indicate a weak interaction. None of the transfected LILR could interact with the 
H37Rv strain of M. tb.
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Given the difference in results observed between heat-killed M. bovis and live BCG, the effect of heat killing 
on receptor binding was assessed using BCG. To achieve this, BCG was grown to exponential phase and heat 
killed prior to incubation with the signalling transfectant lines, and the results were compared with live BCG 
(Fig. 5). LILRB1 and LILRB3 transfectant lines were used as negative controls for this experiment due to their 
lack of interaction with live BCG. The results demonstrate that heat killing of mycobacteria may reduce receptor 
binding and consequent signalling, as evidenced by the reduced signalling observed for LILRB5 incubated with 
heat killed mycobacteria. Thus, the reduction in binding seen after heat killing may indicate that the ligand(s) is 
not heat stable.
LILRB5 is expressed on T cells. To date, characterisation of LILRB5 and its functions are unclear. One 
investigation identified LILRB5 mRNA in NK cells36. In order to investigate LILRB5 surface expression more 
thoroughly, a commercially available LILRB5-specific antibody was used to determine the expression of LILRB5 
on PBMC. A whole blood flow cytometry method was followed to analyse immune cell subsets including mono-
cytes, pDC, mDC, NK, NKT, CD4+ T cells, CD8+ T cells and γ δ T cells on cells derived from healthy controls 
who had received BCG vaccination (Fig. 6).
In agreement with the mRNA expression data described above, LILRB5 was expressed at very low levels on 
monocytes and DC. However, LILRB5 was found to be predominantly expressed on T cells (Fig. 7), and on a 
small percentage of γ δ T cells. To confirm this data, we analysed the mRNA levels of LILRB5 for T cells isolated 
by magnetic separation (Fig. 8).
Figure 1. Expression of LILR encoding transcripts in moDC and MDM samples derived from BCG 
vaccinated and unvaccinated donors, as determined using qPCR analysis. The y axis denotes Ct value, which 
is relative to GAPDH expression. Mann-Whitney analysis demonstrated a significant difference (p < 0.05) 
in MDM expression of LILRA3 (p = 0.027) and LILRB2 (p = 0.025) between samples derived from BCG 
vaccinated and unvaccinated donors. The number of paired samples used for each condition is depicted in 
Table 1.
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Figure 2. Expression of LILR encoding transcripts in moDC samples derived from BCG vaccinated and 
unvaccinated donors, cultured with various mycobacterial species, as determined using qPCR analysis. 
The y axis denotes Ct value, which is relative to GAPDH expression. Mann-Whitney analysis demonstrated a 
significant difference in moDC expression of LILRA3 between untreated and M. bovis treated samples from 
unvaccinated donors (p = 0.028). Furthermore, LILRB5 demonstrated significant differences between untreated 
and BCG treated samples from BCG vaccinated donors (p0.034), and M. bovis and H37Rv treated samples also 
from BCG vaccinated donors (p = 0.041). The number of paired samples used for each condition is depicted in 
Table 1.
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Figure 3. Expression of LILR encoding transcripts in MDM samples derived from BCG vaccinated 
and unvaccinated donors, cultured with various mycobacterial species, as determined using qPCR 
analysis. The y axis denotes Ct value, which is relative to GAPDH expression. Mann-Whitney analysis 
demonstrated a significant difference in MDM expression of LILRA3 between untreated and M. bovis treated 
samples from unvaccinated donors (p = 0.047), and between BCG vaccinated and unvaccinated donors in 
untreated (p = 0.027), BCG treated (p = 0.047) and H37Rv treated (p = 0.047) samples. Furthermore, LILRB2 
demonstrated significant differences between untreated and M. bovis treated samples from unvaccinated donors 
(p0.016), and between BCG vaccinated and unvaccinated donors in untreated (p = 0.025) and H37Rv treated 
samples (p = 0.028).
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While we anticipated LILRB5 expression to be predominantly on antigen presenting cells (APC), with its 
expression on T cells somewhat unusual, LILRB1 is also known to be expressed on T cells, and thus such a prec-
edent exists37.
LILRB5 ligation increases proliferation of cytotoxic, but not helper, T cells. Individual recep-
tors in the LILR family exert functional effects that vary between cell types. The majority of studies to date have 
Figure 4. Engagement of mycobacteria by transfected LILR. Detection of GFP production resulting from 
engagement of LILR with M. tb, M. bovis or BCG. These are representative results from n = 3 experiments, from 
which all data was consistent.
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focussed on the effects of LILR activity on antigen presenting functions of monocytic cells13. Given the unex-
pected expression of LILRB5 on T cells, we investigated the potential functions of LILRB5 by crosslinking this 
receptor and analysing the effects using an allogeneic mixed lymphocyte reaction (Fig. 9).
Crosslinking of LILRB5 was achieved using a mouse anti-human IgG secondary antibody. However as our 
data shows, the secondary antibody alone consistently reduced CD8 T cell proliferation. Nonetheless, LILRB5 was 
able to overcome this effect, and increase proliferation when compared to the anti-IgG secondary antibody alone. 
Specifically, whereas APC pre-treated with LILRB5 antibody resulted a slight increase in T cell proliferation, 
Figure 5. Engagement of BCG and heat killed BCG by transfected LILR. Detection of GFP production 
resulting from engagement of LILR with heat killed BCG, and compared to live BCG from Fig. 4. These are 
representative results from n = 3 experiments, from which all data was consistent.
www.nature.com/scientificreports/
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Figure 6. Expression summary of LILRB5 staining on immune cell subsets. This figure depicts the median 
percentage of each immune cell subset that stained positive for LILRB5 (n = 3), and the corresponding MFI.
Figure 7. Surface expression of LILRB5 on CD4 and CD8 T cells. The secondary antibody alone was used as a 
control for non-specific binding. The results show the binding for three individual donors.
Figure 8. Expression of LILR encoding transcripts in T cell populations. LILRB5 amplification is represented 
in red, and GAPDH amplification is represented in green. LILRB5 was detected in magnetically isolated T cells 
from BCG vaccinated donors, using qPCR. This is a representative result from n = 5 samples, of which all data 
was consistent.
www.nature.com/scientificreports/
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pre-treatment of CD8 T cells produced a significant increase in proliferation compared to the secondary antibody 
alone (p = 0.0049). This was not found in CD4 T cell proliferation, demonstrating that, at least for cytotoxic T 
cells, LILRB5 ligation enhances proliferation.
While the functional relevance of increasing T cell proliferation through LILRB5 signalling needs to be 
further characterised before any conclusions can be drawn, cytotoxic T cells are a fundamental component of 
anti-mycobacterial responses, and unless functionally altered, increased proliferation may be a beneficial factor.
Discussion
With a growing body of evidence to support the existence of ‘innate imprinting’ or ‘trained immunity’, new light 
is being shed on the long term effects of vaccinations, and the ways in which they might shape immune responses. 
Several studies have demonstrated the ability of certain proteins to permanently alter APC phenotype38, and BCG 
vaccination has been shown to increase the expression of activation markers and production of pro-inflammatory 
cytokines in monocytes through epigenetic reprogramming33,39. Therefore, before analysing the effects of myco-
bacterial infection on LILR expression, APC derived from BCG-vaccinated donors were compared with those 
from unvaccinated donors in order to identify any pre-existing differences in LILR expression.
While no differences were observed for moDC between the two groups, two LILR were found to differ in 
expression levels for MDM. LILRA3, the only member of the family to be genomically encoded as a soluble pro-
tein, was expressed at significantly lower levels in MDM from BCG vaccinated donors compared to unvaccinated 
donors. Similarly for LILRB2, a significantly lower expression was also observed for MDM derived from BCG 
vaccinated donors compared to MDM derived from unvaccinated donors.
It is interesting to note that although LILRA3 is designated as an activating receptor for the purposes 
of nomenclature, the functional effects of this receptor are thought to be inhibitory. This protein can only be 
expressed in soluble form, and soluble LILR are thought to antagonise the functions of their cell surface coun-
terparts by blocking ligand recognition40. LILRA3 is thought to inhibit the interactions of the activating recep-
tor LILRA1 in this manner41. Thus, our findings indicate that BCG vaccination leads to the down-regulation 
of two receptors with inhibitory functions, which may be a potentially beneficial response in the presence of 
mycobacteria.
Of all the changes detected in LILR mRNA expression, LILRB5 was the only receptor to be significantly 
up-regulated in response to mycobacterial challenge. In moDC, up-regulation of LILRB5 expression was exclu-
sively seen in cells derived from BCG vaccinated donors, following exposure to mycobacteria. In MDM, only 
exposure to M. bovis elicited this up-regulation, which was again, only seen in cells derived from vaccinated 
donors.
Finding LILRB5 upregulated following exposure to mycobacterium species led us to hypothesise that this 
receptor may have a more pertinent role in infection. By incorporating a reporter system, we analysed the abil-
ity of the mycobacterial species to trigger signalling via direct engagement of transfectant cells. Our results 
Figure 9. Allogeneic mixed lymphocyte reaction. Isolated CD4 of CD8 T cells, or APC, were treated with 
crosslinking LILRB5 antibody, and the resulting proliferation measured using flow cytometry. Crosslinking 
LILRB5 on CD8 T cells was found to significantly increase proliferation (p = 0.0049), as compared to the 
secondary antibody alone, using a two-tailed paired t test. This effect was not observed for CD4 T cells. The 
above data represents n = 4 BCG vaccinated donors.
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demonstrated signalling from LILRA1 and LILRB5, indicating again a potential role for LILBR5 during infec-
tion. Furthermore, as LILRA3 is thought to inhibit LILRA1 through competitive inhibition36, it is interesting to 
note that BCG vaccination appears to reduce LILRA3 expression, possibly resulting in less inhibition of LILRA1 
binding in the presence of mycoabcterial infection. Members of the LILR family and their murine orthologyes 
have previously been shown to bind S.aureus and E.coli34, and lipoteichoic acid has been identified as a putative 
bacterial ligand for the murine PIR-B receptor35. It is therefore possible to speculate that lipoteichoic acid may 
also be a ligand for LILRB5. However, lipoteichoic acid is heat stable42 and therefore its binding would not be 
expected to be lost following heat treatment as seen in our assays. The M. tb cell wall primarily contains mycolic 
acid, lipomannan, and lipoarabinomannan lipids, but these components have also been shown to be very heat 
stable, contributing to the robustness of this bacterium. Nonetheless, TLR-4 was shown to bind a heat-labile anti-
gen which was referred to as ‘heat-sensitive, cell-associated factor’26. Further studies will be necessary to identify 
a mycobacterial ligand for LILRB5.
With limited published information to describe the protein expression profile, ligand specificity and function 
of LILRB5, it is difficult to predict whether changes in LILRB5 expression on APC might be detrimental to elic-
iting an effective immune response. However, LILRA3 together with LILRB5 and LILRB3 were found to be over 
expressed in lesions of patients with lepromatous leprosy, where their overexpression was thought to correspond 
to an ineffective immune response43. If these receptors do decrease the efficiency of immune responses it would 
raise the question of whether BCG vaccination does in fact prime APC in an appropriate way to generate a robust 
T cell response to mycobacterial infection.
LILRB5 mRNA was previously found to be expressed by NK cells36, while the protein has been described on 
the surface of osteoclasts40 and secreted by mast cells44. Other studies have documented LILRB5 up-regulation 
under certain conditions in adipose tissue45, PBMC following IFN treatment of MS46, TNF treated DC47, and 
malignant pleural mesothelioma48. LILRB5 protein was identified in an intracellular compartment of mast cells, 
where although it has been shown to mobilize as a result of crosslinking Fcε RI, its functions remain elusive44.
In an attempt to further characterise this receptor, we analysed the surface expression of LILRB5 on immune 
subsets, using a recently available anti-LILRB5 antibody. LILRB5 was expressed by more than 80% of CD4 and 
CD8 T cells, and on a proportion of γ δ T cells. As regulators of TLR, the role of LILR on T cells may be similar 
to that on APC. Whereas ligation of TLR expressed on APC results in cellular activation and maturation, TLR 
expression on T cells is thought to provide co-stimulatory signals during T cell activation, and promote prolif-
eration and survival in effector cells49–51. TLR2 has also been shown to lower the activation threshold of CD8 T 
cells in mice52.
We examined the effect of cross-linking LILRB5 in an allogeneic mixed lymphocyte reaction. Pre-treatment 
with LILRB5 ligation significantly increased proliferation of CD8 but not CD4 T cells. It is not unusual for LILR 
to have differing functions depending on the type of cell they are expressed on, and therefore, whilst we can con-
clude that one function of LILRB5 may be to increase proliferation of cytotoxic T cells, the expression of LILRB5 
on helper T cells is not associated with either promoting or inhibiting proliferation. These data would support the 
notion that LILRB5 expression on cytotoxic T cells may mediate the threshold of activation.
In conclusion, this study provides evidence that LILR expression and functions are affected by exposure to 
M. bovis and its attenuated strain BCG. LILRB5 is both able to engage our transfectant cells, and is up-regulated 
following exposure to M. Bovis. Further investigation revealed this receptor to be expressed predominantly on T 
cells, and able to enhance cytotoxic T cell proliferation. The presence of LILRB5 on T cells and its apparent ability 
to bind M. bovis warrants further investigation as to whether and how this receptor can influence the immune 
response during mycobacterial infection.
Materials and Methods. Human Study Populations. Ethical approval for this study was granted by 
London and Surrey Borders Research Ethics Committee on 24th May 2010, ref. 10/H0806/41, and this study was 
carried out in accordance with the approved guidelines. Healthy participants were recruited from St George’s, 
University of London, and were not selected with regard to age, sex or ethnic origin, but were asked to provide 
BCG vaccination details. Informed consent was obtained from all participants prior to collection of 50 ml blood 
samples.
Culture of in vitro-derived macrophages and dendritic cells. Peripheral blood mononuclear cells were separated 
using density centrifugation over Ficoll-paque (GE Healthcare, UK). Adherent cells were cultured in RPMI1640 
containing 1% autologous plasma, 1% Penicillin/Streptomycin (Sigma, UK). Monocyte derived macrophages 
(MDM) were differentiated in 50 ng/ml M-CSF (Peprotech, UK) and monocyte derived dendritic cells (moDC) in 
50 ng/ml IL-4 and GM-CSF (Peprotech, UK). Cytokines were replenished every 48 hours. After six days, 0.5 ng/ml 
bacterial lipopolysaccharide (LPS) (Sigma, UK) was added to mature the cells.
Culture of BCG, M. tuberculosis and M. bovis. Thawed aliquots of BCG, M. tuberculosis (H37Rv) and M. bovis 
(AF2122/97) were used to initiate cultures. Original mycobacterial aliquots were kindly provided by Prof P. 
Butcher (St George’s, University of London, UK) and Prof M. Vordermeier (APHA, UK). Each aliquot was cul-
tured at 37 °C for ten days in 10mls of 7H9 broth (Difco Laboratories, UK) supplemented with 0.5% glycerol 
(BCG, M. tuberculosis (Sigma, UK)) or 0.5% sodium pyruvate (M. bovis (Invitrogen, UK)), followed by a further 
ten days in 100 mls of supplemented broth at 37 °C. Colony forming units (CFU) were assessed using 10-fold 
serial dilutions on 7H11 agar plates (Difco Laboratories, UK). The culture was aliquoted and frozen at − 80 °C 
until use.
Infection of moDC and MDM with BCG, M. tuberculosis or M. bovis. Antibiotic-free RPMI was used for culture 
of cells in infection studies. Mycobacteria in the exponential phase of growth were added to cells at a multiplicity 
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of infection (MOI) of 10:1 (M. tuberculosis:cells) and incubated at 37 °C for 24 hours. The cells were then washed 
gently three times with PBS to remove excess bacteria.
RNA extraction and cDNA synthesis. RNA extraction and cDNA synthesis were performed as previously 
described40. Briefly, RNA was extracted from moDC and MDM using an RNeasy Kit (Qiagen, UK) following 
the manufacturers standard protocol. RNA was eluted in 40 μ l of 0.2 μ m sterile filtered H2O (Sigma, UK), and 
underwent a second DNase treatment using a Turbo DNase Free kit (Ambion, USA). Genomic DNA contamina-
tion was assessed by quantitative PCR (qPCR) using a GAPDH reaction. cDNA synthesis was performed using 
Superscript III with an Oligo(dT)20 primer (Invitrogen, UK) at 50 °C for 1 hour, following the manufacturer’s 
standard protocol.
Real-Time Quantitative PCR (qPCR). qPCR was employed to determine the relative levels of all 11 LILR tran-
scripts in moDC and MDM. PCR primers to detect the full-length, membrane-associated protein encoding LILR 
transcripts were supplied by Sigma (Sigma, UK)40. Primer pairs, including the oligonucleotide sequences and 
their final working concentration were used as previously described40. For normalisation, reactions were also used 
to determine the expression of the reference gene GAPDH.
QPCR reactions consisted of 10 μ l of 2× QuantiTect SYBR Green solution (Qiagen, UK), 1 ng cDNA, 2x oligo-
nucleotides and brought to a final volume of 20 μ l with 0.2 μ m filtered H2O (Sigma, UK). Each sample was run in 
triplicate, with an accompanying non-template RNA control run in duplicate for every sample. GAPDH reference 
targets were also run for each sample in order to normalise the results. qPCR was performed on the Stratagene 
Mx3005 Pro PCR analyser (Stratagene, UK), or the Bio-Rad CFX96 real-time detection system (BioRad, UK). 
The cycling parameters were as follows: 95 °C for 15 minutes, followed by 50 cycles of 94 °C for 15 s, 60 °C for 30 s 
and finally 72 °C for 30 s, after which the fluorescence levels of both SYBR Green and the reference dye ROX were 
acquired. Baselines and thresholds were automatically calculated for all reactions on all runs using the Stratagene 
MxPro or CFX manager software. Finally, the standard dissociation reaction was performed between 60 °C and 
95 °C in order to assess the integrity of the PCR products.
Results were exported into qBasePLUS53 to perform the following analyses: After calculating the average 
amplification efficiency (E) of each reaction (as assessed from three independent serial dilutions) using linear 
regression, the relative expression level of each target transcript in each sample was normalised against the ref-
erence gene GAPDH, and then the inter-plate calibrators were used to correct any inter-plate variability. Finally, 
the results were exported to GraphPad Prism to perform statistical analysis. Sample numbers for each analysis 
are shown in Table 1.
Determining mycobacterial binding to reporter cells expressing LILR. A cellular reporter system to assess LILR 
binding was generated as follows: The extracellular region of each LILR was amplified from previously cloned 
sequences. Each LILR PCR product was fused at the 5′ to an haemagglutinin A (HA) epitope preceded by the 
murine Ig k-chain leader sequence, and at the 3′ to the transmembrane domain of human platelet-derived growth 
factor receptor (PDGFR). These HA-tagged, LILR-PDGFR transmembrane constructs were cloned into the vector 
pMx puro which encoded the sequence of the cytoplasmic tail of the human CD3ζ chain (a gift from Dr Alex 
Barrow, St Louis USA)54] using the primers NK1313 (ATGCTTAATTAATCCACCATGGAGACAGAC) and 
NK1314 (CTTCTCGAGCCAAAGCATGATGAGGATG).
Following transient transfection of PLAT-E retroviral packaging cells with the pMx HA-LILR-PDGFR-CD3ζ 
fusion constructs, recombinant retrovirus was used to transduce 2B4 T cell hybridoma cells that had previously 
been stably transfected with a NFAT-GFP reporter construct (a kind gift from Lewis Lanier, UCSF, San Francisco, 
California, USA)55. Hereafter these cells are referred to as 2B4 reporter cells. Following transduction, 2B4 reporter 
cells were sorted using a MoFlo cytometer (Beckman Coulter, Brea, CA, USA) for similar levels of expression of 
Samples derived from BCG Vaccinated donors Samples derived from Unvaccinated donors
moDC HMDM moDC HMDM
Nega BCG
M. 
bovis H37Rvb Nega BCG
M. 
bovis H37Rvb Nega BCG
M. 
bovis H37Rvb Nega BCG
M. 
bovis H37Rvb
LILRA2 11 11 12 12 11 11 12 12 6 6 6 6 6 6 6 6
LILRB1 11 11 12 12 11 11 12 12 6 6 6 6 6 6 6 6
LILRB4 3 3 4 4 3 3 4 4 3 3 3 3 3 3 3 3
LILRB2 6 6 7 7 6 6 7 7 5 5 5 5 5 5 5 5
LILRB3 11 11 12 12 11 11 12 12 6 6 6 6 6 6 6 6
LILRA3 6 6 7 7 6 6 7 7 5 5 5 5 5 5 5 5
LILRA4 6 6 7 7 6 6 7 7 5 5 5 5 5 5 5 5
LILRA6 3 3 4 4 3 3 4 4 3 3 3 3 3 3 3 3
LILRA5 3 3 4 4 3 3 4 4 3 3 3 3 3 3 3 3
LILRA1 3 3 4 4 3 3 4 4 3 3 3 3 3 3 3 3
LILRB5 3 3 4 4 3 3 4 4 3 3 3 3 3 3 3 3
Table 1.  Number of donors included in each RT-PCR experiment. aNeg refers to untreated cells. bH37Rv 
refers to M. tb strain H37Rv.
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each LILR based on the level of expression of the LILR-fused N terminal HA epitope stained with an anti-HA-PE 
monoclonal antibody (Miltenyi Biotec, Bergisch Gladbach, Germany).
2B4 reporter cells were cultured at 105 in 200 μ l RPMI (10% FCS, 1% P/S, and 2.5 μ g/ml amphotericin B (PAA 
(Now GE Healthcare, USA)) per well of a 96 U-bottom plate. Mycobacteria were grown to exponential stage, 
and heat killed at 90 °C for 45 minutes. A separate experiment was performed with live BCG. Mycobacteria were 
added to each well at an MOI of 10:1 (Mycobacteria:cells) and incubated overnight at 37 °C, 5% CO2. The plates 
were then spun at 1000 rpm for one minute and the GFP level was then measured on FACScan using Weasel v2.0 
software. Controls consisted of anti-HA monoclonal antibody (Miltenyi, UK) together with goat anti-mouse IgG 
(Fc) (ThermoScientific, UK) and cell culture only. The data was analysed using FlowJo VX.
Whole blood flow cytometry. Whole blood samples for flow cytometric analysis were prepared by adding the 
appropriate antibodies to 100 μ l of whole blood, or 200 μ l if diluted 1:2 with RPMI (table 2). Isotype control stain-
ing was performed for each patient and each analysis panel. Red blood cells were lysed and samples fixed using 
500 μ l of BD FACS lysing Solution (Becton Dickinson, UK) and incubated for up to 20 minutes. Each sample was 
then analysed on a BD LSR II Flow Cytometer with FACS Diva software (Becton Dickinson, UK).
Gating immune cell subsets for analysis. DC populations were identified by selecting the HLA-DRHi (PE texas 
red) (Invitrogen, UK) positive and Lin− 1 (FITC) (Becton Dickinson, UK) negative population. Within the gated 
DC population, CD123+ (PE Cy5) (Becton Dickinson, UK) staining identified plasmacytoid DC (pDC) and 
CD11c+ (PE Cy7) (BD Pharmingen, UK) identified myeloid DC (mDC).
The monocyte population was identified using forward and side scatter characteristics and individual mono-
cytic subsets were identified by selecting populations based on the intensity of CD16 (PE Cy7) (BD Pharmingen, 
UK) and CD14 (PE texas red) (Invitrogen, UK) staining, which allowed for the identification of classical, inter-
mediate, and non-classical populations.
Lymphocyte populations were identified using forward and side scatter characteristics and T cell popula-
tions were identified by using anti-CD3 (APC-H7) (BD Bioscience), anti-CD4 (AF700) (BD Pharmingen, UK), 
anti-CD8 (PerCP) (BD Bioscience) and anti-γ δ TCR (FITC) (BD Pharmingen, UK). Anti-CD3 antibody was 
plotted against anti-CD56 (PE texas red) (Invitrogen, UK) to distinguish NK cells and NKT cells.
Surface expression of LILRB5 was determined for each subset using an anti-LILRB5 primary antibody (R&D) 
and Anti-Mouse IgG APC (eBioscience, UK) secondary antibody.
Mixed Lymphocyte Reactions. Peripheral blood mononuclear cells were separated from whole blood using 
density centrifugation over Ficoll-paque. T cell populations were purified from non-adherent cells using a CD4 
MicroBeads Kit (Miltenyi, UK) or CD8 Microbeads Kit (Miltenyi, UK) following the manufacturer’s standard 
protocol. LILRB5 crosslinking of APC or T cells was performed using LILRB5 antibody (R&D) crosslinked with 
anti-mouse IgG. Negative controls were treated with anti-mouse IgG alone, or untreated cells. Allogeneic T cells 
were stained using a Cell Trace Violet Proliferation Kit (Life Technologies, UK), following the manufacturer’s 
standard protocol, then cultured with donor APC in RPMI1640 containing 1% Penicillin/Streptomycin for four 
days. Proliferation was determined using flow cytometric analysis on a BD LSR II Flow Cytometer with FACS Diva 
Specificity Conjugate Catalogue No. Supplier
LIN 1 FITC 340546 BD
HLA-DR PE-TR VXMHLDR17 Invitrogen
CD11c PE-Cy7 561356 BD Pharmingen
CD123 PE-Cy5 561009 BD
CD14 PE-TR MHCD1417 Invitrogen
CD16 Pe-Cy7 557744 BD Pharmingen
CD3 APC-H7 641397 BD Bioscience
CD4 AF700 560836 BD Pharmingen
CD8 AF700 557945 BD Pharmingen
γ δ TCR FITC 561995 BD Pharmingen
CD56 PE-TR VXMHCD5617 Invitrogen
LILRB5/LIR8 Purified MAB3065 R&D
Anti-mouse IgG APC 17-4012-82 Ebioscience
Anti-HA PE 130-092-257 Miltenyi
Anti-Mouse IgG PE 31861 Thermo
Mouse IgG2b FITC 11-4732-41 Ebioscience
Mouse IgG1 APC 550854 BD
Mouse IgG1, κ APC-H7 561427 BD
Mouse IgG2a PE-Cy7 552868 BD
Mouse IgG2a PE-TR MG2a17 Invitrogen
Table 2.  Antibodies used in all experiments.
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software. Analysis was completed using FlowJo VX, by gating around the T cell population identified by forward 
and side scatter characteristics, and then the enumeration of T cells stained with Cell Trace Violet was determined.
Statistical Analysis. All statistical analyses were performed using SPSS 20 and GraphPad Prism 6.05, 
based on the median values for all data. Non-parametric tests were used for mRNA expression analysis, with 
Mann-Whitney U-test used to determine significance between unpaired groups. Parametric two-tailed T-Test 
was used for paired samples in the mixed lymphocyte reaction. All p-values were corrected for ties, and values 
below 0.05 were considered significant.
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